LatestISO 17025Janoshik verified
99.77%
HPLC purity
✓ Passed full QC panel
- Variant
- Retatrutide 30 mg
- Lot #
- 900-30
- Labeled
- 30 mg
- Actual
- 30.87 mg
- Tested
- Jan 27, 2026
Metabolic Research
Retatrutide
CAS 2381089-83-2>99% purity
Triple-agonist GLP-1 / GIP / glucagon research peptide.
Dosage
Quantity
1
$59.00
Bundle & Save
Order within --h --m --s to ship today
Cutoff 1:00 PM CST your time.
Lyophilized Fast shipping Secure checkout
Add-onLaboratory prep material
Bacteriostatic (BAC) Water
Solvent for qualified lab workflows.
$10 · 10 ml
Certificate of Analysis
Third-party testedISO/IEC 17025 accredited
Compound Information
Technical specifications
◇ Molecular profile
What is Retatrutide?
- Type
- Synthetic peptide
- CAS number
- 2381089-83-2
- Molecular weight
- 4731.3 g/mol
- Amino acids
- 39
- Fatty acid chain
- C20 diacid
◇ Storage requirements
Stability information
Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
❄
Lyophilized (powder)
−20 °C · 24+ months
◐
Reconstituted
2–8 °C · ~30 days
More in Metabolic Research
All products
Sources & References
Peer-reviewed research
New England Journal of Medicine
Triple hormone-receptor agonism with Retatrutide in obesity — Phase 2 findings
2023
Jastreboff AM, et al.
View source The Lancet
Retatrutide evaluated in adults with type 2 diabetes — Phase 2
2023
Rosenstock J, et al.
View source Nature Medicine
Retatrutide in metabolic dysfunction-associated steatotic liver disease
2024
Sanyal AJ, et al.
View source Lancet Diabetes & Endocrinology
Effects of Retatrutide on body composition
2025
Coskun T, et al.
View source PubMed Central
Triple agonism approaches in obesity pharmacotherapy
2025
View source PubMed Central
Retatrutide as a next-generation obesity therapy candidate
2025
View source PubMed Central
Efficacy and safety of Retatrutide — systematic review
2024
View source ClinicalTrials.gov
Retatrutide clinical trials registry
View sourceRetatrutide
$59.00
Retatrutide
10 mg · $59.00 each
$59.00